Completed NA INTERVENTIONAL 2-arm NCT02534389

Fish Oil Supplement in Rectal Cancer

Fish Oil Supplement Combined With Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Sponsor: AC Camargo Cancer Center

Updated 6 times since 2017 Last updated: Feb 8, 2017 Started: Jan 31, 2015 Primary completion: Jul 31, 2016 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Rectal Neoplasms, this trial is completed. The trial is conducted by AC Camargo Cancer Center and has accumulated 6 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AC Camargo Cancer Center
University of Sao Paulo

Data source: AC Camargo Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil